Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT00414232
Eligibility Criteria:
Inclusion Criteria:
* All of the following questions must be answered "yes" for a patient to be eligible for this protocol.
1. Is there a working diagnosis of rectal cancer? YES NO
2. Will the patient be receiving neoadjuvant concurrent chemotherapy and pelvic radiation? YES NO
3. Is the pelvic radiation planned for a dose of 45-54 Gy and will it be delivered using a standard 3-field technique? YES NO
4. Is the patient ≥ 18 years of age? YES NO
5. Can the patient give informed consent? YES NO
Exclusion Criteria:
* All of the following questions must be answered "no" for a patient to be eligible for this protocol.
1. Has there been prior radiation to the pelvis? YES NO
2. Is the patient in the "special category" designated by the Public Health Service (patients younger than 18, pregnant women, and prisoners)? YES NO
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT00414232
Study Brief:
Protocol Section:
NCT00414232